Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism SSTR5 agonists(Somatostatin receptor 5 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H21FN6 |
InChIKeyUTCVPVMMHVQGPZ-SFHVURJKSA-N |
CAS Registry2374259-11-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperinsulinism | Preclinical | US | 01 Sep 2022 |